🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Not aware of evidence immunosuppression alters natural history of PrCa New data suggesting no need to alter management based on upcoming/past organ transplant. Stan Liauw Vignesh Packiam, MD Ralph Weichselbaum JNCI ncbi.nlm.nih.gov/pubmed/31728517

PIRADS score may help risk stratify men with #ProstateCancer treated with primary RT. Small lesions are well controlled (consider RT alone); PIRADS5 lesions warrant consideration of more aggressive therapy (ADT, dose intensification?). UChicagoCancerCenter authors.elsevier.com/a/1b8yQ3r93nKx…

Updated analysis of ASCENDE-RT shows sustained superiority of brachy boost over external beam boost for biochemical control of #prostatecancer. However no diff in overall or cancer specific survival. And higher toxicity for brachy boost, incl 2 potential grade 5... #ASTRO20

EDU 28: Post-operative Management of Prostate Cancer with Leslie Ballas Rahul Tendulkar, MD Alison Tree 💙 Stan Liauw #ASTRO20 #pcsm #MedEd Fantastic discussion on a very nuanced subject in #radonc 👇 1/

Ever debate giving ADT with RT for prostate cancer in a man w comorbidity? Our trial suggests oral-only ADT (AA with 5ARI instead of LHRHa) has a wider therapeutic ratio- similar bPFS & AR gene expression, with less decline in hormonal QOL. #pcsm #radonc acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

Don’t miss our annual AUA course led by Dr Catalona reviewing the top 100 #prostatecancer papers of the past year! 📚 Saturday 9/11 at 10aET/7aPT #AUA21 aua2021.app.swapcard.com/event/aua-2021… Douglas Dahl Robert Nadler Stan Liauw Armend Szmulewitz

Happy to share the first published trial of local therapy and immunotherapy in unresectable HCC along with Rohan Katipally. Great multi-institutional and multi-disciplinary effort led by Stan Liauw. sciencedirect.com/science/articl…

HOT OF PRESS: Alexandros Papachristofilou et al: SAKK 01/10 The Lancet Oncology for stage IIA-IIB #testicularcancer #seminoma. Full text bit.ly/3eD5n8I Less #chemotherapy AND less #radiotherapy result in (4.5y FU) less toxicity✅ high efficacy✅ guidelines for RT below Congrats!

Cancer-related PSA changes are due to pattern 4 AKA 'real cancer' Pattern 3 and benign contribute similar PSA per unit volume PSA by Volume of Benign, Gleason Pattern 3 and 4 goldjournal.net/article/S0090-… Ciro Andolfi Gladell Paner, MD Matt Cooperberg Andrew Vickers Brian Helfand MD, PhD Stan Liauw

Exciting time Radiation Medicine Program Princess Margaret Cancer Centre! We formally integrated oligometastatic disease into our well known palliative radiotherapy program to provide comprehensive evaluation of patients for SBRT vs. palliative RT options. Read more 👇 mailchi.mp/eb4adfad0a18/r… #RadOnc #Cancer

Joe O’Sullivan presents CHHiP trial update 10-year data confirms 60/20 hypofractionated #radiotherapy as the standard of care for #prostatecancer (mostly intermediate). Good to see late significant GI/GU toxicity <1-2% at 10 years! @asco #GU23 #radonc #pcsm OncoAlert

Register today for the eContouring for Renal SBRT Webinar Tuesday 6/27 at 6 p.m. ET. This webinar offers a comprehensive review of radiation planning & hands-on contouring practice plus a live webinar with Q&A. ow.ly/I9mT50OPzpu Shankar Siva Nick Hardcastle

Wonderful night celebrating our talented residents at our end of year graduation dinner. Looking forward to following the careers of a truly amazing class Jared Hara Rohan Katipally Peter Ferjančič University of Chicago Radiation Oncology

Sign up now for the eContouring for Breast Cancer webinar led by Dr. Mylin Torres. #RadOnc residents can register FREE of charge with support from the ROI Juan A. del Regato Fund at ow.ly/GsuK50Q9sQK. Must be an ASTRO member-in-training for free registration ARRO

G-Minor-ambitious, exciting, and a clinically relevant question: Kudos to MUSIC patients/investigators: sciencedirect.com/science/articl… Editorial by Stan Liauw and me: sciencedirect.com/science/articl… Plz discuss Todd 〽️ Morgan, MD Daniel E Spratt Khurshid Ghani Kevin Ginsburg Rod Dunn Brent Hollenbeck

Proud to share 2-year patient-reported outcomes for our phase II SCIMITAR trial (NCT03541850) of SBRT to the prostate fossa (with or without nodes), out today in JAMA Oncology. jamanetwork.com/journals/jamao…